Media Summary: Manon Allaire, MD, Greater Paris University Hospitals, Paris, France, comments on the current challenges in identifying patients ... Inside the Issue: Optimizing the Diagnosis and Learn how a “watershed” clinical trial in 2020 completely overturned a decade of standard care for liver cancer. In this inaugural ...
First Line Therapy For Advanced - Detailed Analysis & Overview
Manon Allaire, MD, Greater Paris University Hospitals, Paris, France, comments on the current challenges in identifying patients ... Inside the Issue: Optimizing the Diagnosis and Learn how a “watershed” clinical trial in 2020 completely overturned a decade of standard care for liver cancer. In this inaugural ... Piotr Rutkowski, MD, PhD, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland, ... Mark A. Socinski, MD; Corey J. Langer, MD, FACP; Benjamin P. Levy, MD; and Karen Kelly, MD, review data from the ... Catherine T. Frenette, MD, and Darren S. Sigal, MD, talk about the
Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a Dr. Eddie Garon considers the data on immunotherapies for Dr. Suresh Ramalingam, medical oncologist and leader of the Thoracic Oncology Program at Emory ... Ghassan Abou-Alfa, MD, of Memorial Sloan-Kettering Cancer Center, New York City, NY, evaluates rationale and study design of ... São Paulo HIV Clinical Forum 2020 Dr. Sharon Walmsley In this episode of UroNurse, hosted by Vic Senese, RN, BSN, FAUNA, we explore how
In this Video, Dr. Dan covers the common group of tumors that are 'triple negative' for the routine biomarkers to test for in the Ariela Noy, MD, considers factors that impact Laura Fugazzola provides guidance on how to select a Amarnath Challapalli, MBBS, MD, MRCP, FRCR, PhD, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK, ... A Division of Liver Medicine Grand Rounds presented by Ben L. Da, MD, Hepatology Fellow.
